Company Description

ENU Medicines is a biotechnology company developing first-in-class oral therapies for food allergy, leveraging a forward genetics discovery platform to identify and validate novel disease-driving targets. Unlike existing therapies that neutralize circulating IgE or provide allergen-specific desensitization, ENU targets IgE-producing plasma cells at their source to enable durable, disease-modifying treatment